Clinical Trials Logo
  1. Home
  2. Neuropathy, Diabetic
  3. NCT00643760

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

Neuropathy, Diabetic Clinical Trial

Official title:
Study PXN110448: A Dose-response Study of XP13512, Compared With Concurrent Placebo Control and LYRICA(Pregabalin), in Subjects With Neuropathic Pain Associated Withdiabetic Peripheral Neuropathy (DPN)

Clinical Trial Summary

The purpose of this study is to determine whether gabapentin enacarbil (XP13512/GSK1838262), hereafter referred to as GEn is effective in the treatment of neuropathic pain associated with diabetic peripheral neuropathy(DPN)

Clinical Trial Description

This is a dose-response study of XP13512 compared with concurrent placebo control and LYRICA (pregabalin), in subjects with neuropathic pain associated with DPN. Three doses of XP13512 (1200 mg/day, 2400 mg/day and 3600 mg/day) are being evaluated for the management of neuropathic pain associated with DPN. Approximately 392 subjects from 70 to 80 participating sites in the US will be randomized to receive either XP13512 at the above mentioned doses, placebo or pregabalin (300mg/day). ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00643760
Study type Interventional
Source XenoPort, Inc.
Contact
Status Completed
Phase Phase 2
Start date March 2008
Completion date February 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT03195868 - Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy N/A
Completed NCT05703152 - Effect of a Combined Exercise Program on Neuropathic Pain and Perceived Quality of Life in Type 2 Diabetes N/A
Not yet recruiting NCT05783700 - Identification of Biomarkers for the Study of the Diabetic Foot and Evolution.
Not yet recruiting NCT05546138 - Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Recruiting NCT03989063 - Motor Learning in Individuals With Lower Limb Loss and Chronic Diabetes N/A
Completed NCT00422955 - Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy. Phase 3
Completed NCT03495089 - DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy) N/A
Completed NCT04327622 - Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population
Recruiting NCT06376240 - The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes N/A
Completed NCT04287439 - Relaxation and Meditation Techniques on Pain, Fatigue and Quality of Life N/A
Terminated NCT03777956 - The Effect of Lacosamide in Peripheral Neuropathic Pain Phase 2
Recruiting NCT05291975 - Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain N/A
Not yet recruiting NCT05843929 - Prevalence of the Appearance of Diabetic Ulcers in Patients With 3D Insole and LSCI. N/A
Completed NCT05127538 - Balance and Gait in Diabetic Neuropathy N/A
Completed NCT03847129 - Assessments and Interventions for Hand Neuropathy in DM N/A
Completed NCT03700580 - Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer Phase 2
Completed NCT04078516 - Methods of Early Detection and Grading Of Diabetic Peripheral Neuropathy (MEDON)